Helande Innovations

Help shape the future of chronic pain care.

Helande is developing Nervida with a clear ambition: renewed relief with less disruption from repeat procedures. Our initial focus is chronic back pain.

Request investor materials

Explore the opportunity.

Request an investor overview and a conversation with our team. We review each inquiry before sharing confidential materials.

Investor materials and data-room access are confidential and shared at our discretion.

Stage
Preclinical developmentResearch is needed to establish clinical safety and effectiveness.
Initial focus
Chronic back painAddressing the unmet needs of people whose pain returns after treatment.
Team
Medtech and clinical experienceMedical device development, executive leadership, and interventional pain medicine, supported by a scientific advisory board with expertise in neurosurgery and pain medicine.